Epigallocatechin-3-gallate Inhibits Tax-dependent Activation of Nuclear Factor Kappa B and of Matrix Metalloproteinase 9 in Human T-cell Lymphotropic Virus-1 Positive Leukemia Cells

Therapeutic Options for Adult T-Cell Leukemia/Lymphoma

(2013) Ambroise Marçais et al.   Current Oncology Reports

EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells

(2012) Amélie Vézina et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Mechanisms of human T-lymphotropic virus type 1 transmission and disease

(2012) Michael D Lairmore et al.   Current Opinion in Virology

Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro

(2011) Fang Zhou et al.   ACTA PHARMACOLOGICA SINICA

Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor

(2011) Glenn S. Van Aller et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications

(2011) Brahma N. Singh et al.   BIOCHEMICAL PHARMACOLOGY

Activation of mTOR by human T-cell leukemia virus type 1 Tax is important for the transformation of mouse T cells to interleukin-2-independent growth

(2011) Manami Yoshita et al.   CANCER SCIENCE

An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells

(2011) Shin Uota et al.   CANCER SCIENCE

Tea Polyphenols Induce Apoptosis Through Mitochondrial Pathway and by Inhibiting Nuclear Factor-κB and Akt Activation in Human Cervical Cancer Cells

(2011) Madhulika Singh et al.   ONCOLOGY RESEARCH

Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?

(2011) Rihab Nasr et al.   Viruses-Basel

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients

(2011) Daniel A. Rauch et al.   Viruses-Basel

Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFκB and AP-1 in the human breast cancer cell line MDA-MB-231

(2010) Triparna Sen et al.   ANTI-CANCER DRUGS

New cancer treatment strategy using combination of green tea catechins and anticancer drugs

(2010) Masami Suganuma et al.   CANCER SCIENCE

Control of contact-inhibition by 4E-BP1 upregulation

(2010) Rania Azar et al.   CELL CYCLE

Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

(2010) Ali Bazarbachi et al.   JOURNAL OF CLINICAL ONCOLOGY

Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression

(2010) Linda Zane et al.   VIROLOGY

Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis

(2010) Priya Kannian et al.   Viruses-Basel

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)

(2009) G. Kchour et al.   BLOOD

4E-BP1 is a target of Smad4 essential for TGFβ-mediated inhibition of cell proliferation

(2009) Rania Azar et al.   EMBO JOURNAL

Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1

(2008) R. Azar et al.   CELLULAR AND MOLECULAR LIFE SCIENCES